Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin D

Background: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, with symptoms that greatly affect quality of life (QoL). One of the most prevalent symptoms of MS is fatigue, also one of the main factors reducing QoL. Low levels of vitamin D (VD) are associated with...

Full description

Bibliographic Details
Main Authors: Antonio Ianniello, Andrea Sottosanti, Giovanna Borriello, Massimo Vincenti
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Clinical and Translational Neuroscience
Subjects:
Online Access:https://www.mdpi.com/2514-183X/7/2/12
_version_ 1797595332764237824
author Antonio Ianniello
Andrea Sottosanti
Giovanna Borriello
Massimo Vincenti
author_facet Antonio Ianniello
Andrea Sottosanti
Giovanna Borriello
Massimo Vincenti
author_sort Antonio Ianniello
collection DOAJ
description Background: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, with symptoms that greatly affect quality of life (QoL). One of the most prevalent symptoms of MS is fatigue, also one of the main factors reducing QoL. Low levels of vitamin D (VD) are associated with worse QoL and with increased risk of developing more severe forms of the disease. Methods: In this cross-sectional study, we compared perceptions of quality of life and fatigue in 324 patients, subdivided into four groups, according to their treatment: high-dose VD therapy only, disease-modifying therapy (DMT) only, both treatments, and no treatments. All subjects completed the MSQOL-54 and the FSS questionnaires via an online survey. Results: High-dose VD treatment was associated with an increased perception of physical QoL (83.60 vs. 66.92, <i>p</i> < 0.001), mental QoL (75.52 vs. 59.80, <i>p</i> < 0.001), and fatigue (1.89 vs. 2.98, <i>p</i> < 0.001), compared to the DMT-only group. Treatment with DMT was associated with a worse perception of physical QoL compared to no treatment (70.58 vs. 76.53, <i>p</i> = 0.024). Conclusions: high-dose VD treatment is well-tolerated and associated with an increased perception of QoL in people with MS.
first_indexed 2024-03-11T02:35:52Z
format Article
id doaj.art-7de1ce451d4e4cbd8e363a374bddc167
institution Directory Open Access Journal
issn 2514-183X
language English
last_indexed 2024-03-11T02:35:52Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Clinical and Translational Neuroscience
spelling doaj.art-7de1ce451d4e4cbd8e363a374bddc1672023-11-18T09:57:31ZengMDPI AGClinical and Translational Neuroscience2514-183X2023-04-01721210.3390/ctn7020012Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin DAntonio Ianniello0Andrea Sottosanti1Giovanna Borriello2Massimo Vincenti3Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Medicine, University of Padova, 35128 Padua, ItalyDepartment of Neurology, San Pietro Fatebenefratelli, 00189 Rome, ItalyAssociazione Italiana Protocollo Coimbra, 35020 Legnaro, ItalyBackground: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system, with symptoms that greatly affect quality of life (QoL). One of the most prevalent symptoms of MS is fatigue, also one of the main factors reducing QoL. Low levels of vitamin D (VD) are associated with worse QoL and with increased risk of developing more severe forms of the disease. Methods: In this cross-sectional study, we compared perceptions of quality of life and fatigue in 324 patients, subdivided into four groups, according to their treatment: high-dose VD therapy only, disease-modifying therapy (DMT) only, both treatments, and no treatments. All subjects completed the MSQOL-54 and the FSS questionnaires via an online survey. Results: High-dose VD treatment was associated with an increased perception of physical QoL (83.60 vs. 66.92, <i>p</i> < 0.001), mental QoL (75.52 vs. 59.80, <i>p</i> < 0.001), and fatigue (1.89 vs. 2.98, <i>p</i> < 0.001), compared to the DMT-only group. Treatment with DMT was associated with a worse perception of physical QoL compared to no treatment (70.58 vs. 76.53, <i>p</i> = 0.024). Conclusions: high-dose VD treatment is well-tolerated and associated with an increased perception of QoL in people with MS.https://www.mdpi.com/2514-183X/7/2/12multiple sclerosisvitamin DCoimbra protocolquality of lifemental healthphysical health
spellingShingle Antonio Ianniello
Andrea Sottosanti
Giovanna Borriello
Massimo Vincenti
Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin D
Clinical and Translational Neuroscience
multiple sclerosis
vitamin D
Coimbra protocol
quality of life
mental health
physical health
title Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin D
title_full Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin D
title_fullStr Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin D
title_full_unstemmed Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin D
title_short Perception of Quality of Life and Fatigue in Multiple Sclerosis Patients Treated with High-Dose Vitamin D
title_sort perception of quality of life and fatigue in multiple sclerosis patients treated with high dose vitamin d
topic multiple sclerosis
vitamin D
Coimbra protocol
quality of life
mental health
physical health
url https://www.mdpi.com/2514-183X/7/2/12
work_keys_str_mv AT antonioianniello perceptionofqualityoflifeandfatigueinmultiplesclerosispatientstreatedwithhighdosevitamind
AT andreasottosanti perceptionofqualityoflifeandfatigueinmultiplesclerosispatientstreatedwithhighdosevitamind
AT giovannaborriello perceptionofqualityoflifeandfatigueinmultiplesclerosispatientstreatedwithhighdosevitamind
AT massimovincenti perceptionofqualityoflifeandfatigueinmultiplesclerosispatientstreatedwithhighdosevitamind